Produktbild: Nano Drug Delivery Systems for Colon Cancer
Neu

Nano Drug Delivery Systems for Colon Cancer Innovations, Challenges, and Applications

185,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.07.2026

Herausgeber

Arun Kumar Singh + weitere

Verlag

Elsevier

Seitenzahl

400

Maße (L/B/H)

19,1/23,6/2,4 cm

Gewicht

822 g

Sprache

Englisch

ISBN

978-0-443-40443-6

Beschreibung

Portrait

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.

Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak, India, where he was awarded fellowship support from the University Grants Commission (UGC), New Delhi. Dr. Kumar’s research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. Dr. Kumar has published over 35 research and review articles in peer-reviewed national and international journals and has authored and edited 04 national and international books, along with several book chapters. He also holds 04 Indian patents in the areas of drug discovery and nanomedicine. His academic achievements have been recognized with several honors, including the Backbone Award (2025–26) from CGC University, Mohali, and the Devi Lal Memorial Award (2020–21) from JCD Vidyapeeth, Sirsa, for excellence in teaching and research. Dr. Kumar serves on the editorial boards of multiple international journals and acts as a reviewer for several reputed publications. He has delivered more than 30 oral and poster presentations at national and international scientific meetings and actively contributes to academic governance and policy development through his roles in ethical committees, inspection teams, examination committees, and university Boards of Studies.

Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.

Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence.

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.07.2026

Herausgeber

Verlag

Elsevier

Seitenzahl

400

Maße (L/B/H)

19,1/23,6/2,4 cm

Gewicht

822 g

Sprache

Englisch

ISBN

978-0-443-40443-6

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Nano Drug Delivery Systems for Colon Cancer
  • 1. Etiology and pathophysiology of colon cancer
    2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer
    3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer
    4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
    5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer
    6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery
    7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer
    8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer
    9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents
    10. Surface modified Metal Nanoparticles in Colon Cancer Therapy
    11. Nano-based Phyto drug delivery systems for the management of colon cancer
    12. Role of polymeric nanoparticles for the treatment of Colon cancer
    13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer
    14. Regulatory framework in the Nanomedicine targeting Colon Cancer
    15. Current and future perspectives of nanomedicine in colon cancer treatment